Innate immune reprogramming to overcome therapy resistance in high-risk colorectal cancer
Duration: 48 months, Funding volume: € 800,000
Decoding cellular senescence in glioblastoma (GlioAge)
Duration: 48 months, Funding volume: € 898,970
Characterizing and targeting the Ewing sarcoma microenvironment to overcome resistance to therapy
Duration: 48 months, Funding volume: € 799,510